Rethinking the “Drug Dealer”: Harsh Penalties for Drug Supply are Counterproductive, Says New Report

Press Release December 17, 2019
Media Contact

Matt Sutton 212-613-8026
[email protected]

New York, NY – Today, the Drug Policy Alliance released a new report making the case for rethinking the way the United States responds to the “drug dealer.” Beyond being merely ineffective, the harsh criminalization of supply-side drug market activity may actually make drug use more dangerous, increasing overdose deaths and leading to more violence in communities. 

The report demonstrates how the United States’ punitive approach to people who sell or distribute drugs—rooted in stigma, ignorance and fear, rather than evidence—has done nothing to reduce the harms of drug use or improve public safety, while instead creating new problems and compounding those that already exist. It builds on a set of videos, which DPA released earlier this year, that features people who have been criminalized by the drug trade. 

“With a record 70,000 deaths from accidental overdose in 2017, people are understandably searching for solutions, but applying harsh penalties to drug sellers scapegoats people who are more often than not drug users as well, while ignoring the larger issue,” said Lindsay LaSalle, Managing Director of Public Health Law and Policy at the Drug Policy Alliance. “Instead, we should be using the same resources and determination to reduce the actual harms of both drug use and drug prohibition, repair the criminal legal system’s discriminatory response to the drug trade, and increase access to evidence-based treatment and support services that benefit health, public safety and economic opportunity in the long term.”

Among the flaws in the current system, the report highlights the following:

The report’s analysis further points out how the current approach causes serious harms to health and public safety:

Accordingly, DPA has provided a set of tailored recommendations based on three broad principles:

With the report public, DPA aims to expand the current public dialogue around drug reform, to focus on who the people now labeled “drug dealers” in the United States really are and how we, as a society, can respond to them in ways that will keep people and communities safer and healthier.

“Despite the challenges of discussing supply-side drug policy reform in the midst of an overdose crisis, we cannot be silent while policymakers repeat the discriminatory, ineffective, expensive and dangerous mistakes of the past,” Alyssa Stryker, the report’s author and former criminal justice policy manager at the Drug Policy Alliance, said in the report.

DPA stressed that the report represents an effort to begin to more meaningfully address the situation of people who are involved in the drug trade. This is an important step for which people within the organization, as well as many allies–especially in the formerly incarcerated persons community–have long advocated.

“Too often, public discourse draws an arbitrary line between people who use drugs and people who sell drugs–in practice, this creates space for the current gentler rhetoric around opioid user and the draconian policy responses to people who sell fentanyl,” said Kassandra Frederique, Managing Director of Policy Advocacy and Campaigns at the Drug Policy Alliance. “We want to be clear: our reform community is everyone impacted by the war on drugs, and that includes people who use drugs and people who sell drugs. We thank the movement for its patience and are excited to continue the work to build a bigger, broader, and more responsible movement that centers not only people who use drugs, but also people who sell them.”

The full report can be found at

A young woman holds a sign that says "End the Drug War."

Sign up for updates from DPA.